Proven maintained efficacy and safety in patients with paranoid schizophrenia after direct switch to risperidone long-acting injectable

被引：0
|
作者：
Parellada, E
Kissling, W
Bouhours, F
Gallhofer, B
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Tech Univ Munich, Dept Psychiat, D-8000 Munich, Germany
[3] Univ Giessen, Ctr Psychiat, D-35390 Giessen, Germany
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of long-acting injectable risperidone in patients with schizophrenia
    Bouhours, P
    Schreiner, A
    Rendall, MR
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 171
  • [2] Long-acting injectable risperidone: Efficacy and safety
    Kane, JM
    Eerdekens, M
    Keith, SJ
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
  • [3] Maintained efficacy and safety in patients switched directly to risperidone long-acting injectable: The French experience
    Llorca, P
    Peretti, C
    Tyrode, Y
    Moreau-Mallet, V
    Coulaud-Navarre, A
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S402 - S402
  • [4] Obese patients with schizophrenia and schizoaffective disorder: Efficacy of injectable long-acting risperidone
    Permuy, RT
    Turner, MS
    Bouhours, P
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 175 - 175
  • [5] Efficacy and safety of long-acting risperidone: A direct switch from oral atypicals
    Schmauss, M
    Schreiner, A
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S397 - S398
  • [6] Direct switch from atypical antipsychotics to long-acting injectable risperidone in schizophrenia and schizoaffective disorders
    Vauth, R
    Kusters, J
    Braendle, D
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 177 - 177
  • [7] Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
    Kane, JM
    Eerdekens, M
    Lindenmayer, JP
    Keith, SJ
    Lesem, M
    Karcher, K
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06): : 1125 - 1132
  • [8] Risperidone long-acting injectable improves efficacy and safety in schizophrenic patients after changing from oral risperidone
    Kusters, J
    Glue, P
    Katsafouros, K
    Boon, H
    Medori, R
    Parellada, E
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 : S79 - S79
  • [9] Patients with high baseline PANSS scores improve after direct switch to risperidone long-acting injectable
    Nick, B
    Möller, H
    Tzebelikos, E
    Braendle, D
    Durval, R
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S237 - S237
  • [10] Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia
    Catalan, Rosa
    Penades, Rafael
    [J]. JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 95 - 105
12345